SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stéphanie Pascarella, Sophie Clément, Michael T. Dill, Stéphanie Conzelmann, Martin Lagging, Gabriele Missale, Avidan U. Neumann, Jean-Michel Pawlotsky, Stefan Zeuzem, Laura Rubbia-Brandt, Pierre-Yves Bochud, Francesco Negro, Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C, Liver International, 2013, 33, 1
  2. 2
    Aimei Li, Wuqi Song, Jun Qian, Yujun Li, Junming He, Qingmeng Zhang, Wenhui Li, Aixia Zhai, Wenping Kao, Yunlong Hu, Hui Li, Jing Wu, Hong Ling, Zhaohua Zhong, Fengmin Zhang, MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1, The International Journal of Biochemistry & Cell Biology, 2013, 45, 4, 858

    CrossRef

  3. 3
    Kuo-Chih Tseng, Jian-Liang Chou, Hsien-Bin Huang, Chih-Wei Tseng, Shu-Fen Wu, Michael W. Y. Chan, SOCS-1 Promoter Methylation and Treatment Response in Chronic Hepatitis C Patients Receiving Pegylated-Interferon/Ribavirin, Journal of Clinical Immunology, 2013, 33, 6, 1110

    CrossRef

  4. 4
    Stéphanie Pascarella, Sophie Clément, Kévin Guilloux, Stéphanie Conzelmann, François Penin, Francesco Negro, Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: Comparison between different genotypes and core protein sequence analysis, Journal of Medical Virology, 2011, 83, 6
  5. You have full text access to this Open Access content5
    Shintaro Tomita, Kei Ishibashi, Koichi Hashimoto, Takashi Sugino, Tomohiko Yanagida, Nobuhiro Kushida, Keiichi Shishido, Ken Aikawa, Yuka Sato, Tatsuo Suzutani, Osamu Yamaguchi, Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α, Cancer Science, 2011, 102, 1
  6. 6
    Z Zídek, P Anzenbacher, E Kmoníčková, Current status and challenges of cytokine pharmacology, British Journal of Pharmacology, 2009, 157, 3
  7. 7
    Seung-Ho Hong, Okki Cho, Koyngmin Kim, Ho-Joon Shin, Sergei V Kotenko, Sun Park, Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells, Virus Research, 2007, 126, 1-2, 245

    CrossRef

  8. 8
    Valerio Pazienza, Sophie Clément, Paolo Pugnale, Stéphanie Conzelman, Michelangelo Foti, Alessandra Mangia, Francesco Negro, The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms, Hepatology, 2007, 45, 5
  9. 9
    Kathrin Zitzmann, Stephan Brand, Sebastian Baehs, Burkhard Göke, Jennifer Meinecke, Gerald Spöttl, Heinrich Meyer, Christoph J. Auernhammer, Novel interferon-λs induce antiproliferative effects in neuroendocrine tumor cells, Biochemical and Biophysical Research Communications, 2006, 344, 4, 1334

    CrossRef

  10. 10
    Cecile Krejsa, Mark Rogge, Wolfgang Sadee, Protein therapeutics: new applications for pharmacogenetics, Nature Reviews Drug Discovery, 2006, 5, 6, 507

    CrossRef

  11. 11
    Hiromichi Dansako, Kazuhito Naka, Masanori Ikeda, Nobuyuki Kato, Hepatitis C virus proteins exhibit conflicting effects on the interferon system in human hepatocyte cells, Biochemical and Biophysical Research Communications, 2005, 336, 2, 458

    CrossRef

  12. 12
    Stephan Brand, Kathrin Zitzmann, Julia Dambacher, Florian Beigel, Torsten Olszak, George Vlotides, Sören T. Eichhorst, Burkhard Göke, Helmut Diepolder, Christoph J. Auernhammer, SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29, Biochemical and Biophysical Research Communications, 2005, 331, 2, 543

    CrossRef